Hearing Loss Trial, Recruiting NCT06726928 Sponsor: Acandis GmbH Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06726928
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have pulsatile tinnitus (a rhythmic, heartbeat-like ringing or whooshing in your ear) that has lasted more than three months and significantly affects your daily life
  • When a doctor presses on the jugular vein on the same side as your affected ear, the sound temporarily stops
  • Imaging scans (MRI or CT) show a narrowing in a specific vein in your head called the lateral sinus
  • Other causes of your pulsatile tinnitus have been ruled out through MRI and CT scans
  • The narrowing is located in the main or equally important vein on that side of your head
  • Pressure measurements taken during a procedure under general anaesthetic show a specific pressure difference across the narrowing (confirm with trial site for exact thresholds)
  • You are actively seeking treatment for your pulsatile tinnitus
  • You are willing to receive a specific medical device called the SiREX® Stent as part of the treatment
  • You are able and willing to provide written consent to participate

Who may not be able to join:

  • Your tinnitus is not pulsatile, or your pulsatile tinnitus is not caused by a narrowing in the lateral sinus vein
  • The pressure difference across the narrowing in your vein does not meet the required minimum level (confirm with trial site)
  • The size or shape of your vein is not suitable for the stent device being used
  • Your blood vessels are too twisted or too narrow for the procedure to be safely performed
  • You are unable to take blood-thinning or anti-clotting medications, or you did not receive these medications before the procedure
  • You have had a recent bleed around the brain (subarachnoid haemorrhage)
  • You currently have an active bacterial infection
  • You have a known allergy or sensitivity to nickel-titanium (the material the stent is made from)
  • You are currently pregnant or breastfeeding
  • You are already taking part in another clinical trial
  • You have experienced a life-threatening event in the last 6 months
  • Your life expectancy is less than 12 months
  • You have a serious ongoing condition such as cancer, dementia, or alcohol or drug dependency that could make it difficult to attend follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +49 7231 155000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Acandis GmbH
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Disappearance of pulsatile tinnitus at 90 (± 20) days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov